logo
Select company
Select metric
5.86%Debt to Assets Ratio
VS
Market
72
Sector
63
Industry
53
History
43
$ 2.32Close
$ 1.66 - $ 12.28 52-Week Range
Ticker Information

Ticker

IOVA

Company Name

IOVANCE BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

IOVANCE BIOTHERAPEUTICS INC - Debt to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IOVA - Debt to Assets Historical data
DateTotal AssetsTotal DebtDebt to Assets Ratio
6/30/2025$ 907.44M$ 53.17M5.86%
3/31/2025$ 966.74M$ 53.72M5.56%
12/31/2024$ 910.43M$ 58.26M6.4%
9/30/2024$ 991.12M$ 78.94M7.96%
6/30/2024$ 964.32M$ 81.68M8.47%
3/31/2024$ 869.83M$ 84.37M9.7%
12/31/2023$ 780.35M$ 75.86M9.72%
9/30/2023$ 852.32M$ 79.48M9.32%
6/30/2023$ 757.29M$ 80.71M10.66%
3/31/2023$ 824.77M$ 83.23M10.09%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IOVANCE BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) Debt to Assets stands at 1.39%.
  • Over the past 5 years, IOVANCE BIOTHERAPEUTICS INC's average Debt to Assets has been 8.76%.
  • The median Debt to Assets for IOVANCE BIOTHERAPEUTICS INC during this period was 8.97%
  • IOVANCE BIOTHERAPEUTICS INC reached its highest Debt to Assets over the past 5 years at 14.67%.
  • The lowest Debt to Assets recorded by IOVANCE BIOTHERAPEUTICS INC in the same timeframe 1.39%

IOVANCE BIOTHERAPEUTICS INC's Debt to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Debt to Assets Benchmarks
CompanyDebt to Assets
XERS : XERIS BIOPHARMA HOLDINGS INC 76.86%RCUS : ARCUS BIOSCIENCES INC 9.02%DNA : GINKGO BIOWORKS HOLDINGS INC 34.84%AKBA : AKEBIA THERAPEUTICS INC 13.81%AUPH : AURINIA PHARMACEUTICALS INC 16.28%MNKD : MANNKIND CORP 69.89%GERN : GERON CORP 44.99%STOK : STOKE THERAPEUTICS INC 0%KROS : KEROS THERAPEUTICS INC 2.37%DAWN : DAY ONE BIOPHARMACEUTICALS INC 0.58%

Definition of Debt to Assets Ratio

[Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
Debt / Assets
(=) Debt to Assets
Debt to Assets for IOVANCE BIOTHERAPEUTICS INC is calculated as follows: Debt [ $ 10.91M ] / Assets [ $ 782.29M ]
(=) Debt to Assets [ 1.39% ]

IOVA - Debt to Assets Ratio, Last 5 years

1.39%

Minimum

Sep 30, 2020

14.67%

Maximum

Sep 30, 2022

8.76%

Average

8.97%

Median

Debt to Assets Benchmark Analysis

The chart above depicts the distribution of Debt to Assets for companies in the Total Stock Market. The average Debt to Assets of the companies is 26.32% with a standard deviation of 24.51%.
The following table provides additional summary stats:
Debt to Assets in the Market:
filtered constituents4.38K
min0%
max116.6%
average26.32%
median21.04%
std24.51%